Recombinant human activated protein C upregulates the release of soluble fractalkine from human endothelial cells

No abstract is available for this paper.

• Publication year

  2006

• Venue

  British Journal of Haematology

• Publication date

  2006-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1365-2141.2006.06059.xPMID 16681644
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Endothelial protein C receptor and protease-activated receptor-1 mediate induction of a wound-healing phenotype in human keratinocytes by activated protein C.

  2005cited by this paper
• Drotrecogin alfa (activated) treatment in severe sepsis from the global open-label trial ENHANCE: Further evidence for survival and safety and implications for early treatment*

  2005cited by this paper
• Protease-activated Receptor-1 Signaling by Activated Protein C in Cytokine-perturbed Endothelial Cells Is Distinct from Thrombin Signaling*

  2005cited by this paper
• Fractalkine/CX3CL1 production by human airway smooth muscle cells: induction by IFN-γ and TNF-α and regulation by TGF-β and corticosteroids

  2004cited by this paper
• Fractalkine/CX3CL1 production by human airway smooth muscle cells: induction by IFN-gamma and TNF-alpha and regulation by TGF-beta and corticosteroids.

  2004cited by this paper
• Fractalkine in Vascular Biology: From Basic Research to Clinical Disease

  2004cited by this paper
• Effect of drotrecogin alfa (activated) on human endothelial cell permeability and Rho kinase signaling

  2004cited by this paper
• Activated Protein C Induces Endothelial Cell Proliferation by Mitogen-Activated Protein Kinase Activation In Vitro and Angiogenesis In Vivo

  2004cited by this paper
• Activated protein C stimulates proliferation, migration and wound closure, inhibits apoptosis and upregulates MMP-2 activity in cultured human keratinocytes.

  2004cited by this paper
• Inhibition of staurosporine-induced apoptosis of endothelial cells by activated protein C requires protease-activated receptor-1 and endothelial cell protein C receptor.

  2003cited by this paper
• Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective

  2003cited by this paper
• Stabilization of monocyte chemoattractant protein-1-mRNA by activated protein C

  2003cited by this paper
• Effects of drotrecogin alfa (activated) on organ dysfunction in the PROWESS trial*

  2003cited by this paper
• Drotrecogin alfa (activated) (recombinant human activated protein C) reduces host coagulopathy response in patients with severe sepsis

  2003cited by this paper
• Activated Protein C Inhibits Lipopolysaccharide-Induced Tumor Necrosis Factor-α Production by Inhibiting Activation of both Nuclear Factor-κB and Activator Protein-1 in Human Monocytes

  2002cited by this paper
• Recombinant human activated protein C attenuates the inflammatory response in endothelium and monocytes by modulating nuclear factor-&kgr;B

  2002cited by this paper
• Pharmacokinetic‐pharmacodynamic analysis of drotrecogin alfa (activated) in patients with severe sepsis

  2002cited by this paper
• Activation of Endothelial Cell Protease Activated Receptor 1 by the Protein C Pathway

  2002cited by this paper
• Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1).

  2001cited by this paper
• Gene Expression Profile of Antithrombotic Protein C Defines New Mechanisms Modulating Inflammation and Apoptosis*

  2001cited by this paper
• Fractalkine and vascular injury.

  2001cited by this paper
• Efficacy and safety of recombinant human activated protein C for severe sepsis.

  2001cited by this paper
• The endothelial cell protein C receptor (EPCR) functions as a primary receptor for protein C activation on endothelial cells in arteries, veins, and capillaries.

  1999cited by this paper
• Development and Characterization of Conditionally Immortalized Osteoblast Precursor Cell Lines from Human Bone Marrow Stroma

  1998cited by this paper
• Identification and Molecular Characterization of Fractalkine Receptor CX3CR1, which Mediates Both Leukocyte Migration and Adhesion

  1997cited by this paper
• A new class of membrane-bound chemokine with a CX3C motif

  1997cited by this paper
• Identification, cloning, and regulation of a novel endothelial cell protein C/activated protein C receptor.

  1994cited by this paper
• Selective inhibitory effects of the anticoagulant activated protein C on the responses of human mononuclear phagocytes to LPS, IFN-gamma, or phorbol ester.

  1994cited by this paper
• Inflammation and Coagulation: Linked Processes Potentially Regulated Through a Common Pathway Mediated by Protein C

  1991cited by this paper
• Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity.

  1991cited by this paper
• Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria.

  1973cited by this paper

• Protein C Pretreatment Protects Endothelial Cells from SARS-CoV-2-Induced Activation

  2024cites this paper
• Endothelial cell signalling of APC and thrombin : the involvement of protein kinase C

  2013cites this paper
• Is EPCR a multi-ligand receptor? Pros and cons

  2012cites this paper
• Francisella tularensis Suppresses the Proinflammatory Response of Endothelial Cells via the Endothelial Protein C Receptor

  2010cites this paper
• Cells via the Endothelial Protein C Receptor Proinflammatory Response of Endothelial Suppresses the Francisella tularensis

  2010cites this paper
• Protective mechanisms of activated protein C in severe inflammatory disorders

  2009influential citation
• Proteinase-activated receptor-1 mediates allogeneic CD8+ T cell-induced apoptosis of vascular endothelial cells

  2009cites this paper
• Thrombin‐induced expression of endothelial CX3CL1 potentiates monocyte CCL2 production and transendothelial migration

  2008cites this paper
• Protective effects of activated protein C in sepsis

  2008cites this paper
• Activated protein C: therapeutic implications for Alzheimer's disease.

  2007cites this paper
• Expression and regulation of CCL18 in synovial fluid neutrophils of patients with rheumatoid arthritis

  2007cites this paper
• Thrombin-induced Expression of Endothelial Cx3cl1 Potentiates Monocyte Ccl2 Production and Transendothelial Migration

  year unknowncites this paper